AI BIOTECH ENVEDA DOUBLES VALUATION TO $2B Enveda has raised new funding led by Catalio Capital alongside Iconiq, doubling its valuation to $2 Billion. The company uses AI to discover drugs from plants and microbes and has produced 17 candidates since 2019, including pills targeting post-GLP-1 weight maintenance, atopic dermatitis and inflammatory bowel disease.

Big news today: @Envestnet_ entered a definitive agreement to acquire @Vestmark! I’ve been involved in dozens of exits, but this one is very close to my heart. I started Vestmark with my fraternity brothers (and my actual brother), writing the first few lines of code myself by hand, all the way through today where the company supports 2T+ in assets, 5+ million accounts, and is leading the way with cutting edge AI solutions in a heavily regulated space. I’m so proud of the 100s of incredible individuals who made it their life mission to build Vestmark, working alongside me, and then carrying the torch beyond my time as a 9-9-6 founder. We only got here because of you! I’m also grateful for all of those who worked so diligently to unite these two great companies: the employees, the leadership teams, the respective boards, and an extra shoutout to Karl Roessner and Colin Motley. Looking ahead, I’m comforted knowing Vestmark will be in the extremely capable hands of Chris Todd, a trusted, seasoned operator in the space. This is just the team to maintain Vestmark’s trajectory! As this chapter comes to a close, I’ve got a lot to look forward to. I’m back to working deep in the code, building something new and close to my MIT roots. Stay tuned for the launch! -Dave Blundin The deal is expected to close in the fourth quarter, subject to customary closing conditions. Press Release here:

“Pushing the envelope in virtually every aspect possible.” @ServeTheHome takes a deep dive into AMD Instinct MI455X and CDNA 5, exploring the memory, bandwidth, packaging and rack-scale advances behind the next era of Instinct accelerators. 🚀

ENHYPEN 5th ENniversary Night 🗓️ 2025. 11. 22 (SAT) 11:30PM (KST) ▶️ENHYPEN Official YouTube: ▶️ENHYPEN Weverse Live: #ENHYPEN# #엔하이픈# #ENHYPEN5thAnniversary# #2025ENniversary#

Founder + CEO of biotech firm @enveda shares why the most successful drugs in history trace back to living cells, and how his team built the world's first sequencer to decode them. Watch the full conversation with @viswacolluru:

O’KEEFE INVESTIGATES DUPLICATE ABSENTEE BALLOT RETURN ENVELOPES IN DETROIT, MICHIGAN GOES DOOR TO DOOR INTERVIEWING AFFECTED VOTERS "That's illegal right? you couldn't... scrape one of them off?" “They probably sent her two ballots, and she just signed them, I guess.” "Keep them [cameras] pointed from my house... Do you want me to get the dog?"